Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 50% ± 11% | |
lung | 15 studies | 42% ± 18% | |
intestine | 11 studies | 42% ± 18% | |
kidney | 8 studies | 40% ± 16% | |
eye | 8 studies | 35% ± 16% | |
placenta | 5 studies | 30% ± 10% | |
bone marrow | 4 studies | 38% ± 12% | |
uterus | 4 studies | 59% ± 14% | |
lymph node | 4 studies | 49% ± 9% | |
breast | 4 studies | 55% ± 5% | |
pancreas | 3 studies | 61% ± 25% | |
brain | 3 studies | 24% ± 3% | |
esophagus | 3 studies | 39% ± 30% | |
thymus | 3 studies | 61% ± 31% | |
prostate | 3 studies | 36% ± 7% | |
liver | 3 studies | 37% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 4622.32 | 180 / 180 | 100% | 76.57 | 430 / 430 |
thymus | 100% | 2103.52 | 652 / 653 | 100% | 46.69 | 605 / 605 |
brain | 100% | 1676.43 | 2637 / 2642 | 100% | 43.03 | 705 / 705 |
pancreas | 100% | 1525.36 | 328 / 328 | 99% | 37.48 | 177 / 178 |
prostate | 100% | 2772.52 | 245 / 245 | 99% | 59.95 | 499 / 502 |
uterus | 100% | 3315.39 | 170 / 170 | 99% | 44.36 | 453 / 459 |
skin | 100% | 2141.05 | 1809 / 1809 | 99% | 35.11 | 465 / 472 |
breast | 100% | 2566.86 | 459 / 459 | 98% | 41.22 | 1097 / 1118 |
esophagus | 100% | 1733.19 | 1445 / 1445 | 98% | 25.07 | 179 / 183 |
lung | 100% | 1950.81 | 576 / 578 | 98% | 27.96 | 1127 / 1155 |
bladder | 100% | 2379.90 | 21 / 21 | 97% | 38.58 | 488 / 504 |
adrenal gland | 100% | 1723.05 | 258 / 258 | 96% | 46.93 | 220 / 230 |
liver | 100% | 1012.94 | 225 / 226 | 96% | 31.15 | 388 / 406 |
intestine | 100% | 1842.41 | 966 / 966 | 95% | 38.35 | 501 / 527 |
stomach | 100% | 1563.99 | 359 / 359 | 94% | 32.23 | 268 / 286 |
kidney | 100% | 1724.10 | 89 / 89 | 93% | 27.79 | 840 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 40.22 | 29 / 29 |
spleen | 100% | 1450.52 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 55.23 | 1 / 1 |
blood vessel | 100% | 3187.77 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2178.88 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 1719.72 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 59.59 | 79 / 80 |
muscle | 98% | 939.64 | 783 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 29.70 | 43 / 45 |
peripheral blood | 64% | 817.73 | 598 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050890 | Biological process | cognition |
GO_0021678 | Biological process | third ventricle development |
GO_0014819 | Biological process | regulation of skeletal muscle contraction |
GO_0021540 | Biological process | corpus callosum morphogenesis |
GO_0009791 | Biological process | post-embryonic development |
GO_0036343 | Biological process | psychomotor behavior |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0016607 | Cellular component | nuclear speck |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | C12orf57 |
Protein name | Protein C10 |
Synonyms | C10 |
Description | FUNCTION: In brain, may be required for corpus callosum development. . |
Accessions | F5GXW5 Q99622 ENST00000537087.5 U3KQ85 ENST00000544681.1 U3KQ07 ENST00000229281.6 ENST00000545581.5 ENST00000540506.2 |